Henry Schein, Inc. (NASDAQ:HSIC) will release its earnings data before the market opens on Tuesday, October 31st. Analysts expect Henry Schein to post earnings of $0.90 per share for the quarter. Henry Schein has set its FY17 guidance at $7.17-7.30 EPS.

Henry Schein (NASDAQ:HSIC) last posted its quarterly earnings results on Tuesday, August 8th. The company reported $0.88 earnings per share for the quarter, topping the consensus estimate of $0.86 by $0.02. The business had revenue of $3.06 billion during the quarter, compared to the consensus estimate of $3.05 billion. Henry Schein had a net margin of 4.59% and a return on equity of 19.91%. The firm’s revenue for the quarter was up 6.4% on a year-over-year basis. During the same period in the previous year, the firm posted $0.82 earnings per share. On average, analysts expect Henry Schein to post $3.64 EPS for the current fiscal year and $4.01 EPS for the next fiscal year.

Henry Schein, Inc. (NASDAQ HSIC) traded up 0.23% during mid-day trading on Tuesday, reaching $83.04. 495,524 shares of the company’s stock traded hands. Henry Schein, Inc. has a 12-month low of $73.11 and a 12-month high of $93.50. The stock has a 50-day moving average price of $82.35 and a 200-day moving average price of $87.30. The stock has a market capitalization of $13.13 billion, a PE ratio of 24.27 and a beta of 1.09.

Henry Schein declared that its board has approved a stock buyback plan on Monday, September 18th that allows the company to buyback $400.00 million in shares. This buyback authorization allows the company to reacquire up to 6.3% of its stock through open market purchases. Stock buyback plans are usually a sign that the company’s leadership believes its shares are undervalued.

In related news, SVP Paul Rose sold 2,126 shares of Henry Schein stock in a transaction dated Wednesday, September 6th. The shares were sold at an average price of $172.51, for a total transaction of $366,756.26. Following the completion of the sale, the senior vice president now owns 17,841 shares in the company, valued at approximately $3,077,750.91. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Company insiders own 1.19% of the company’s stock.

WARNING: “Henry Schein, Inc. (HSIC) Scheduled to Post Earnings on Tuesday” was reported by American Banking News and is owned by of American Banking News. If you are viewing this news story on another publication, it was stolen and republished in violation of United States and international trademark and copyright legislation. The correct version of this news story can be viewed at https://www.americanbankingnews.com/2017/10/24/henry-schein-inc-hsic-scheduled-to-post-earnings-on-tuesday.html.

HSIC has been the subject of several research reports. UBS AG reiterated a “buy” rating on shares of Henry Schein in a research report on Friday, September 15th. Northcoast Research upgraded shares of Henry Schein from a “neutral” rating to a “buy” rating and set a $109.00 target price for the company in a report on Monday, August 7th. Robert W. Baird set a $95.00 target price on shares of Henry Schein and gave the stock a “buy” rating in a report on Thursday, October 19th. Morgan Stanley began coverage on shares of Henry Schein in a report on Thursday, September 21st. They issued an “equal weight” rating and a $88.00 target price for the company. Finally, Stifel Nicolaus restated a “hold” rating and issued a $89.00 target price on shares of Henry Schein in a report on Thursday, October 19th. One analyst has rated the stock with a sell rating, eleven have assigned a hold rating and six have assigned a buy rating to the company’s stock. The stock has an average rating of “Hold” and an average target price of $92.89.

About Henry Schein

Henry Schein, Inc is a provider of healthcare products and services primarily to office-based dental, animal health and medical practitioners. The Company operates through two segments: healthcare distribution, and technology and value-added services. The healthcare distribution segment distributes consumable products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products and vitamins.

Earnings History for Henry Schein (NASDAQ:HSIC)

Receive News & Ratings for Henry Schein Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein Inc. and related companies with MarketBeat.com's FREE daily email newsletter.